Buy Neurocrine Biosciences Stock | NBIX Stock Price & Latest News | Public
NBIX

Neurocrine Biosciences

$0.00 (0.00%)Today
    View Neurocrine Biosciences (NBIX) stock trends here

    About NBIX

    Neurocrine Biosciences, Inc. operates as a product based bio-pharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company product includes INGREZZA. Neurocri...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.81
    0.33
    -0.14
    -0.62
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    $0.59

    Actual EPS
    Q1 2021

    Stats

    Market Cap$10,74B
    Volume7,31k
    Price-to-Earnings Ratio123.84
    Dividend Rate
    Dividend Yield
    1 Year High$136.26
    1 Year Low$72.14
    Open$114.69
    High$116.11
    Low$114.25

    Buy any stock with any amount of money.

    Download the App
    Download the app